Drug Type Small molecule drug |
Synonyms Pardoprunox, Pardoprunox hydrochloride (USAN), DU 126891 HYDROCHLORIDE + [4] |
Action agonists |
Mechanism 5-HT1A receptor agonists(Serotonin 1a (5-HT1a) receptor agonists), D2 receptor agonists(Dopamine D2 receptor agonists), D3 receptor agonists(Dopamine D3 receptor agonists) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC12H16ClN3O2 |
InChIKeyNQRIKTDKFHAOKC-UHFFFAOYSA-N |
CAS Registry269718-83-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D09366 | Pardoprunox Hydrochloride | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Motor Disorders | Phase 3 | United States | 01 Mar 2007 | |
Motor Disorders | Phase 3 | Argentina | 01 Mar 2007 | |
Motor Disorders | Phase 3 | Brazil | 01 Mar 2007 | |
Motor Disorders | Phase 3 | Bulgaria | 01 Mar 2007 | |
Motor Disorders | Phase 3 | Canada | 01 Mar 2007 | |
Motor Disorders | Phase 3 | Chile | 01 Mar 2007 | |
Motor Disorders | Phase 3 | Colombia | 01 Mar 2007 | |
Motor Disorders | Phase 3 | Latvia | 01 Mar 2007 | |
Motor Disorders | Phase 3 | Lithuania | 01 Mar 2007 | |
Motor Disorders | Phase 3 | Peru | 01 Mar 2007 |
Phase 3 | 295 | vwyqgotoby(tehryeqbvt) = ervolwwiyd smrmbgwvbg (jkwrqlvfyo ) | - | 01 May 2012 | |||
Placebo | vwyqgotoby(tehryeqbvt) = vmgohjmjgm smrmbgwvbg (jkwrqlvfyo ) |